"Bromocriptine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion.
Descriptor ID |
D001971
|
MeSH Number(s) |
D03.132.327.412.100 D03.633.400.439.131 D03.633.400.562.100
|
Concept/Terms |
Bromocriptine- Bromocriptine
- 2-Bromo-alpha-ergokryptine
- 2 Bromo alpha ergokryptine
- Bromocryptin
- 2-Bromoergokryptine
- 2 Bromoergokryptine
- Bromocriptin
- 2-Bromoergocryptine
- 2 Bromoergocryptine
- 2-Bromo-alpha-ergocryptine
- 2 Bromo alpha ergocryptine
2-Bromoergocryptine Mesylate- 2-Bromoergocryptine Mesylate
- 2 Bromoergocryptine Mesylate
- Mesylate, 2-Bromoergocryptine
- Bromocriptine Mesylate
- Mesylate, Bromocriptine
- 2-Bromoergocryptine Methanesulfonate
- 2 Bromoergocryptine Methanesulfonate
- Methanesulfonate, 2-Bromoergocryptine
|
Below are MeSH descriptors whose meaning is more general than "Bromocriptine".
Below are MeSH descriptors whose meaning is more specific than "Bromocriptine".
This graph shows the total number of publications written about "Bromocriptine" by people in this website by year, and whether "Bromocriptine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 1 | 1 |
2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bromocriptine" by people in Profiles.
-
Development of a novel patient-reported measure for acromegaly: the Acro-TSQ. Pituitary. 2019 Dec; 22(6):581-593.
-
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Mov Disord. 2005 May; 20(5):523-39.
-
Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Ann Neurol. 1993 Nov; 34(5):710-4.
-
Dopaminergic agonists in the treatment of Parkinson's disease. Neurol Clin. 1992 May; 10(2):527-40.
-
Dopaminergic agonists in the treatment of Parkinson's disease. Neurology. 1990 Oct; 40(10 Suppl 3):suppl 50-4; discussion 54-7.
-
Agonist substitution in advanced Parkinson's disease. Neurology. 1989 Aug; 39(8):1121-2.
-
Morphea after bromocriptine therapy. Int J Dermatol. 1989 Apr; 28(3):177-9.
-
Bromocriptine-induced myoclonus. Neurology. 1987 May; 37(5):885.
-
L-5-HTP-induced myoclonic jumping behavior in guinea pigs: an update. Adv Neurol. 1986; 43:509-17.
-
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide. Neurology. 1985 May; 35(5):749-51.